Urinary angiotensinogen as a marker of intrarenal angiotensin II activity associated with deterioration of renal function in patients with chronic kidney disease

Journal of the American Society of Nephrology

Volumn 18, Issue 5, 2007, Pages 1558-1565

  Yamamoto, Tatsuo ^a   Nakagawa, Tsutomu ^b   Suzuki, Hiroyuki ^a   Ohashi, Naro ^a   Fukasawa, Hirotaka ^a   Fujigaki, Yoshihide ^a   Kato, Akihiko ^a   Nakamura, Yukio ^b   Suzuki, Fumiaki ^b   Hishida, Akira ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b GIFU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; ANGIOTENSINOGEN; COLLAGEN TYPE 4; LOSARTAN;

ADULT; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE URINE LEVEL; DRUG EFFECT; DRUG MECHANISM; FEMALE; FOLLOW UP; HUMAN; IMMUNOHISTOCHEMISTRY; KIDNEY FUNCTION; MALE; PRIORITY JOURNAL; PROTEIN URINE LEVEL;

EID: 34248144931     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2006060554     Document Type: Article

References (40)

1. McCullough PA: Cardiovascular disease in chronic kidney disease from a cardiologist's perspective. Curr Opin Nephrol Hypertens 13: 591-600, 2004
2. Pellicano R, Kerr PG, Atkins RC: What have we learned from clinical trials on prevention? Kidney Int Suppl 94: S101-S106, 2005
3. Nishiyama A, Seth DM, Navar LG: Renal interstitial fluid concentrations of angiotensins I and II in anesthetized rats. Hypertension 39: 129-134, 2002
4. Danser AH, Saris JJ, Schuijt MP, van Kats JP: Is there a local renin-angiotensin system in the heart? Cardiovasc Res 44: 252-265, 1999
5. Warnock DG: Prevention, protection, and the intrarenal renin-angiotensin systems. Semin Nephrol 21: 593-602, 2001
6. Campbell DJ, Lawrence AC, Towrie A, Kladis A, Valentijn AJ: Differential regulation of angiotensin peptide levels in plasma and kidney of the rat. Hypertension 18: 763-773, 1991
7. Bailie MD, Rector FC Jr, Seldin DW: Angiotensin II in arterial and renal venous plasma and renal lymph in the dog. J Clin Invest 50: 119-126, 1971
8. Navar LG, Imig JD, Zou L, Wang CT: Intrarenal production of angiotensin II. Semin Nephrol 17: 412-422, 1997
9. Navar LG, Harrison-Bernard LM, Nishiyama A, Kobori H: Regulation of intrarenal angiotensin II in hypertension. Hypertension 39: 316-322, 2002
10. Kobori H, Nishiyama A, Harrison-Bernard LM, Navar LG: Urinary angiotensinogen as an indicator of intrarenal angiotensin status in hypertension. Hypertension 41: 42-49, 2003
11. Kobori H, Harrison-Bernard LM, Navar LG: Urinary excretion of angiotensinogen reflects intrarenal angiotensinogen production. Kidney Int 61: 579-585, 2002
12. Lai KN, Leung JC, Lai KB, To WY, Yeung VT, Lai FM: Gene expression of the renin-angiotensin system in human kidney. J Hypertens 16: 91-102, 1998
13. Kobori H, Harrison-Bernard LM, Navar LG: Enhancement of angiotensinogen expression in angiotensin II-dependent hypertension. Hypertension 37: 1329-1335, 2001
14. Graciano ML, Cavaglieri Rde C, Delle H, Dominguez WV, Casarini DE, Malheiros DM, Noronha IL: Intrarenal renin-angiotensin system is upregulated in experimental model of progressive renal disease induced by chronic inhibition of nitric oxide synthesis. J Am Soc Nephrol 15: 1805-1815, 2004
15. Del Prete D, Gambaro G, Lupo A, Anglani F, Brezzi B, Magistroni R, Graziotto R, Furci L, Modena F, Bernich P, Albertazzi A, D'Angelo A, Maschio G: Precocious activation of genes of the renin-angiotensin system and the fibrogenic cascade in IgA glomerulonephritis. Kidney Int 64: 149-159, 2003
16. Reams G, Villarreal D, Wu Z, Bauer JH: Urinary angiotensin II: A marker of renal tissue activity? Nephron 67: 450-458, 1994
17. Gould AB, Green D: Kinetics of the human renin and human substrate reaction. Cardiovasc Res 5: 86-89, 1971
18. Klett C, Nobiling R, Gierschik P, Hackenfhal E: Angiotensin II stimulates the synthesis of angiotensinogen in hepatocytes by inhibiting adenylylcyclase activity and stabilizing angiotensinogen mRNA. J Biol Chem 268: 25095-25107, 1993
19. Li J, Brasier AR: Angiotensinogen gene activation by angiotensin II is mediated by the rel A (nuclear factor-kappaB p65) transcription factor: One mechanism for the renin angiotensin system positive feedback loop in hepatocytes. Mol Endocrinol 10: 252-264, 1996
20. Tamura K, Umemura S, Nyui N, Hibi K, Ishigami T, Kihara M, Toya Y, Ishii M: Activation of angiotensinogen gene in cardiac myocytes by angiotensin II and mechanical stretch. Am J Physiol 275: R1-R9, 1998
21. Ingelfinger JR, Jung F, Diamant D, Haveran L, Lee E, Brem A, Tang SS: Rat proximal tubule cell line transformed with origin-defective SV40 DNA: Autocrine ANG II feedback. Am J Physiol 276: F218-F227, 1999
22. Kobori H, Nishiyama A, Abe Y, Navar LG: Enhancement of intrarenal angiotensinogen in Dahl salt-sensitive rats on high salt diet. Hypertension 41: 592-597, 2003
23. Cockcroft DW, Gault MH: Prediction of creatinine clearance from serum creatinine. Nephron 16: 31-41, 1976
24. Pierrat A, Gravier E, Saunders C, Caira MV, Ait-Djafer Z, Legras B, Mallie JP: Predicting GFR in children and adults: A comparison of the Cockcroft-Gault, Schwartz, and modification of diet in renal disease formulas. Kidney Int 64: 1425-1436, 2003
25. Morganti A, Sala C, Turolo L, Palermo A, Zanchetti A: Participation of the renin-angiotensin system in the maintenance of blood pressure during changes in posture in patients with essential hypertension. J Hypertens 3: 55-61, 1985
26. Suzuki F, Nakagawa T, Kakidachi H, Murakami K, Inagami T, Nakamura Y: The dominant role of the prosegment of prorenin in determining the rate of activation by acid or trypsin: Studies with molecular chimeras. Biochem Biophys Res Commun 267: 577-580, 2000
27. Lindeman RD, Tobin J, Shock NW: Longitudinal study on the rate of decline in renal function with age. J Am Geriatr Soc 33: 278-285, 1985
28. Bakris GL, Williams M, Dworkin L, Elliott WJ, Epstein M, Toto R, Tuttle K, Douglas J, Hsueh W, Sowers J: Preserving renal function in adults with hypertension and diabetes: A consensus approach. Am J Kidney Dis 36: 646-661, 2000
29. Fukasawa H, Yamamoto T, Suzuki H, Togawa A, Ohashi N, Fujigaki Y, Uchida C, Aoki M, Hosono M, Kitagawa M, Hishida A: Treatment with anti-TGF-beta antibody ameliorates chronic progressive nephritis by inhibiting Smad/ TGF-beta signaling. Kidney Int 65: 63-74, 2004
30. Weening JJ, D'Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, Balow JE, Bruijn JA, Cook T, Ferrario F, Fogo AB, Ginzler EM, Hebert L, Hill G, Hill P, Jennette JC, Kong NC, Lesavre P, Lockshin M, Looi LM, Makino H, Moura LA, Nagata M: The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol 15: 241-250, 2004
31. Prieto-Carrasquero MC, Harrison-Bernard LM, Kobori H, Ozawa Y, Hering-Smith KS, Hamm LL, Navar LG: Enhancement of collecting duct renin in angiotensin II-dependent hypertensive rats. Hypertension 44: 223-229, 2004
32. Watanabe H, Sanada H, Shigetomi S, Katoh T, Watanabe T: Urinary excretion of type IV collagen as a specific indicator of the progression of diabetic nephropathy. Nephron 86: 27-35, 2000
33. Io H, Hamada C, Fukui M, Horikoshi S, Tomino Y: Relationship between levels of urinary type IV collagen and renal injuries in patients with IgA nephropathy. J Clin Lab Anal 18: 14-18, 2004
34. Nishiyama A, Yoshizumi M, Rahman M, Kobori H, Seth DM, Miyatake A, Zhang GX, Yao L, Hitomi H, Shokoji T, Kiyomoto H, Kimura S, Tamaki T, Kohno M, Abe Y: Effects of AT1 receptor blockade on renal injury and mitogen-activated protein activity in Dahl salt-sensitive rats. Kidney Int 65: 972-981, 2004
35. Menard J, Campbell DJ, Azizi M, Gonzales M-F: Synergistic effects of ACE inhibition and Ang II antagonism on blood pressure, cardiac weight, and renin in spontaneously hypertensive rats. Circulation 96: 3072-3078, 1997
36. Brasier AR, Li J: Mechanisms for inducible control of angiotensinogen gene transcription. Hypertension 27: 465-475, 1996
37. Suzaki Y, Ozawa Y, Kobori H: Quantification of human angiotensinogen by a novel sandwich ELISA. Peptides 27: 3000-3002, 2006
38. Lantelme P, Rohrwasser A, Vincent M, Cheng T, Gardier S, Legedz L, Bricca G, Lalouel J-M, Millon H: Significance of urinary angiotensinogen in essential hypertension as a function of plasma renin and aldosterone status. J Hypertens 23: 785-792, 2005
39. Clauser E, Bouhnik J, Gonzales MF, Corvol P, Menard J: Influence of converting-enzyme inhibition on rat des-angiotensin I-angiotensinogen. Am J Physiol Endocrinol Metab 246: E129-E133, 1984
40. Jaramillo HN, Sambhi MP, Bouhnik J, Corvol P, Menard J: Liver angiotensinogen synthesis and release during captopril treatment in sodium-depleted rats. Endocrinology 120: 1384-1390, 1987